Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

1,620 trials

Showing 20 of 1,620 results

Testing effectiveness (Phase 2)Study completedNCT00026143
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 60
Not applicableUnknownNCT02498808
What this trial is testing

Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?

Who this might be right for
ArthritisVasculitis
University of Oxford 85
Testing effectiveness (Phase 2)WithdrawnNCT00814606
What this trial is testing

A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

Who this might be right for
Hepatitis CHepatitis C Virus
University of Chicago
Large-scale testing (Phase 3)Study completedNCT00516321
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 687
Not applicableStudy completedNCT00468182
What this trial is testing

Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Rutgers, The State University of New Jersey 24
Early research (Phase 1)Study completedNCT00111397
What this trial is testing

Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection

Who this might be right for
Mycobacterium Avium-Intracellulare Infection
National Institute of Allergy and Infectious Diseases (NIAID) 2
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Post-approval studies (Phase 4)Study completedNCT01842191
What this trial is testing

Efficacy of Fish Oil in Multiple Sclerosis

Who this might be right for
Relapsing- Remitting Multiple Sclerosis
Coordinación de Investigación en Salud, Mexico 50
Testing effectiveness (Phase 2)Study completedNCT01176552
What this trial is testing

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 35
Post-approval studies (Phase 4)Study completedNCT00146068
What this trial is testing

EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of North Carolina 30
Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75
Testing effectiveness (Phase 2)UnknownNCT01834963
What this trial is testing

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Kansai Hepatobiliary Oncology Group 66
Large-scale testing (Phase 3)Ended earlyNCT03283397
What this trial is testing

A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bosnalijek D.D 301
Large-scale testing (Phase 3)Study completedNCT01088659
What this trial is testing

Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 50
Not applicableUnknownNCT01111435
What this trial is testing

A Prospective Study of Spasticity in Individuals With Multiple Sclerosis

Who this might be right for
Spasticity
Fraser, Cira, Ph.D., RN, ACNS-BC 110
Testing effectiveness (Phase 2)Study completedNCT00059813
What this trial is testing

Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Recurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01217359
What this trial is testing

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

Who this might be right for
Hepatitis C
University of North Carolina, Chapel Hill 22
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Large-scale testing (Phase 3)Study completedNCT00915577
What this trial is testing

Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe

Who this might be right for
Multiple Sclerosis
Biogen 74
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation